These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 27631143)

  • 1. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
    Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
    J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
    Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
    Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
    J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
    Geladé K; Bink M; Janssen TW; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive effects of neurofeedback in adolescents with ADHD: a randomized controlled trial.
    Bink M; van Nieuwenhuizen C; Popma A; Bongers IL; van Boxtel GJ
    J Clin Psychiatry; 2014 May; 75(5):535-42. PubMed ID: 24922488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD.
    Geladé K; Janssen TWP; Bink M; Twisk JWR; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2018 May; 27(5):581-593. PubMed ID: 29098467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder.
    van Dongen-Boomsma M; Vollebregt MA; Slaats-Willemse D; Buitelaar JK
    J Clin Psychiatry; 2013 Aug; 74(8):821-7. PubMed ID: 24021501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
    Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
    Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
    Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
    Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up.
    Meisel V; Servera M; Garcia-Banda G; Cardo E; Moreno I
    Biol Psychol; 2013 Sep; 94(1):12-21. PubMed ID: 23665196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of theta/beta neurofeedback on EEG power spectra in children with attention deficit hyperactivity disorder.
    Janssen TWP; Geladé K; Bink M; van Mourik R; Twisk JWR; Maras A; Oosterlaan J
    Clin Neurophysiol; 2020 Jun; 131(6):1332-1341. PubMed ID: 32304847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning curves of theta/beta neurofeedback in children with ADHD.
    Janssen TWP; Bink M; Weeda WD; Geladé K; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2017 May; 26(5):573-582. PubMed ID: 27866283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG Neurofeedback Training in Children With Attention Deficit/Hyperactivity Disorder: A Cognitive and Behavioral Outcome Study.
    Shereena EA; Gupta RK; Bennett CN; Sagar KJV; Rajeswaran J
    Clin EEG Neurosci; 2019 Jul; 50(4):242-255. PubMed ID: 30453757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.
    Purper-Ouakil D; Blasco-Fontecilla H; Ros T; Acquaviva E; Banaschewski T; Baumeister S; Bousquet E; Bussalb A; Delhaye M; Delorme R; Drechsler R; Goujon A; Häge A; Kaiser A; Mayaud L; Mechler K; Menache C; Revol O; Tagwerker F; Walitza S; Werling AM; Bioulac S; Brandeis D
    J Child Psychol Psychiatry; 2022 Feb; 63(2):187-198. PubMed ID: 34165190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
    Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
    JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD.
    Bioulac S; Purper-Ouakil D; Ros T; Blasco-Fontecilla H; Prats M; Mayaud L; Brandeis D
    BMC Psychiatry; 2019 Aug; 19(1):237. PubMed ID: 31370811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial.
    Sugaya LS; Salum GA; de Sousa Gurgel W; de Morais EM; Del Prette G; Pilatti CD; Dalmaso BB; Leibenluft E; Rohde LA; Polanczyk GV
    Lancet Child Adolesc Health; 2022 Dec; 6(12):845-856. PubMed ID: 36306807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.